BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2433247)

  • 1. [New monoclonal antibodies in the diagnosis of gastrointestinal cancers].
    Heptner G; Domschke S; Domschke W
    Internist (Berl); 1986 Nov; 27(11):723-8. PubMed ID: 2433247
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies in the diagnosis and treatment of malignant conditions.
    Allum WH; Macdonald F; Fielding JW
    Surg Annu; 1986; 18():41-64. PubMed ID: 2417343
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of a monoclonal antibody (CA 19-9 system) in gastrointestinal disease--in comparison with CEA and IAP].
    Furukawa M; Kozaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):25-30. PubMed ID: 3858395
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor markers in malignancies of the gastrointestinal tract].
    von Kleist S; Hohneck A
    Internist (Berl); 1982 Jan; 23(1):10-2. PubMed ID: 6175599
    [No Abstract]   [Full Text] [Related]  

  • 7. [Crucial diagnostic points of tumor markers: gastrointestinal tumors].
    Klöppel G
    Verh Dtsch Ges Pathol; 1986; 70():159-71. PubMed ID: 2435072
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis of early cancer with monoclonal antibodies].
    Yachi A; Ibayashi Y; Imai K
    Gan No Rinsho; 1988 Aug; 34(10):1216-21. PubMed ID: 2459426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor markers in digestive oncology: present status of the topic and prospects for the future].
    Desaive C
    Rev Med Liege; 1987 Nov; 42(22):881-7. PubMed ID: 2447625
    [No Abstract]   [Full Text] [Related]  

  • 10. [Monoclonal antibodies against tumor-associated antigens of the gastrointestinal tract. Experimental and clinical outlook].
    Schmiegel WH; Kalthoff H
    Dtsch Med Wochenschr; 1985 Dec; 110(50):1943-9. PubMed ID: 3908048
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gastrointestinal cancer antigen and carcinoembryonic antigen in chronic pancreatopathies and pancreatic tumors].
    Piantino P; Cerchier A; Tappero GF; Pecchio F; Ghisetti V
    Minerva Med; 1985 Jul; 76(28-29):1331-4. PubMed ID: 4022426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of fecal detection of cancer-associated antigens using monoclonal antibodies in the diagnosis of colorectal cancer].
    Yuan M
    Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):497-500, 511-2. PubMed ID: 2086118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical value of the plasma-CEA-concentrations in the primary diagnosis of malignoma of the digestive tract].
    Aver IO; Münch L; Epping J; Schmid L
    Z Gastroenterol Verh; 1976; (11):73-7. PubMed ID: 65868
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
    Mennini G; Silecchia G; Zanna C; Cucchiara G; Spadaro G; Greco E; Basoli A; Speranza V
    Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects of the CEA test.
    Laurence JR; Neville AM
    Bull Cancer; 1976; 63(4):473-81. PubMed ID: 1021177
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of immunologic markers in the diagnosis and monitoring of large-intestinal neoplasms].
    Harłozińska-Szmyrka A
    Pol Arch Med Wewn; 1992; 88(2-3):181-9. PubMed ID: 1492024
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ganglioside and carcinoembryonic antigens in the diagnosis of malignant tumors of the gastrointestinal tract].
    Ivanov PK; Samoĭlenko VM
    Vopr Onkol; 1984; 30(9):55-9. PubMed ID: 6495695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunodetection of cancers containing carcinoembryonic antigen and alpha-fetoprotein.
    Wang XH; Wang LS; Shi L; Yang J; Ma XQ; Luo HN; Zhou ZF; Xu GC; Li GX
    Chin Med J (Engl); 1988 Mar; 101(3):175-80. PubMed ID: 2457471
    [No Abstract]   [Full Text] [Related]  

  • 19. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
    Dienst C; Clodius T; Oldörp T; Uhlenbruck G; Diehl V
    Med Klin (Munich); 1987 Jan; 82(2):45-50. PubMed ID: 3470595
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
    McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
    Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.